Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/6062
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCorley, Amanda-
dc.contributor.authorUllman, Amanda J.-
dc.contributor.authorMarsh, Nicole-
dc.contributor.authorGenzel, Jodie-
dc.contributor.authorLarsen, Emily N.-
dc.contributor.authorYoung, Emily-
dc.contributor.authorBooker, Catriona-
dc.contributor.authorHarris, Patrick N. A.-
dc.contributor.authorRickard, Claire M.-
dc.date.accessioned2024-06-20T00:30:04Z-
dc.date.available2024-06-20T00:30:04Z-
dc.date.issued2023-
dc.identifier.citationHeart & Lung, 2023 (57) p.45-53en
dc.identifier.urihttps://dora.health.qld.gov.au/qldresearchjspui/handle/1/6062-
dc.description.abstract• Bundled dressing and securement interventions for PIVCs are feasible and acceptable. • In this small sample, no significant differences were found in PIVC failure. • These bundled interventions should now be tested in a definitive trial. • They may be an innovative solution to the currently high PIVC failure rates. Peripheral intravenous catheters (PIVCs) are ubiquitous in acute care settings however failure rates are unacceptably high, with around half failing before prescribed treatment is complete. The most effective dressing and securement option to prolong PIVC longevity is unclear. To determine feasibility of conducting a definitive randomized controlled trial (RCT) investigating evidence-based securement bundles (medical adhesive tapes and supplementary securement products) to reduce PIVC failure. In this pilot non-masked 3-group RCT, adults requiring a PIVC for >24 hrs were randomized to Standard care (bordered polyurethane dressing plus non-sterile tape over extension tubing), Securement Bundle 1 (two sterile tape strips over PIVC hub plus Standard care) or Securement Bundle 2 (Bundle 1 plus tubular bandage) with allocation concealed until study entry. Exclusions: laboratory-confirmed positive blood culture, current/high-risk of skin tear, or study product allergy. Primary outcome: feasibility (eligibility, recruitment, retention, protocol fidelity, participant/staff satisfaction). Secondary outcomes: PIVC failure, PIVC dwell time, adverse skin events, PIVC colonization and cost. Of 109 randomized participants, 104 were included in final analyses. Feasibility outcomes were met, except eligibility criterion (79%). Absolute PIVC failure was 38.2% (13/34) for Bundle 2, 25% (9/36) for Bundle 1 and 23.5% (8/34) for Standard care. Incidence rate ratio for PIVC failure/1000 catheter days, compared to Standard care, was 1.1 (95% confidence interval [CI] 0.4–2.7) and 2.1 (95% CI 0.9–5.1) for Bundles 1 and 2, respectively. A large RCT testing securement bundles is feasible, with adjustment to screening processes. Innovative dressing and securement solutions are needed to reduce unacceptable PIVC failure rates. Trial registration ACTRN12619000026123.-
dc.titleA pilot randomized controlled trial of securement bundles to reduce peripheral intravenous catheter failure-
dc.identifier.doi10.1016/j.hrtlng.2022.07.015-
dc.relation.urlhttps://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,athens&db=ccm&AN=161009622&site=ehost-live-
dc.identifier.journaltitleHeart & Lung-
dc.identifier.risid4420-
dc.description.pages45-53-
dc.description.volume57-
item.grantfulltextnone-
item.fulltextNo Fulltext-
Appears in Sites:Children's Health Queensland Publications
Show simple item record

Page view(s)

36
checked on Nov 25, 2024

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.